Bronchoplastic Procedures for Bronchial Carcinoma

Publisher Website
Google Scholar
Abstract
In a 22-year period from 1962 to 1984, 51 patients with malignant lung disease had a sleeve resection performed. In 33 % of the patients, pneumonectomy was contraindicated because of limited lung function. The operative mortality was 8 %. Six per cent of the patients developed complications after the operation. The 5-year survival of the total group of patients was 30 %. Patients with lesions classified as stage 1 and stage 2 had the best prognosis, with a 5- and 10-year survival of 43.5 % and 27 %, respectively. In patients classified as stage 3 and stage 4, the 5- and 10-year survival was 20 %. A postoperative measurement of regional ventilation and perfusion indicated that the function of the remaining lung was presumably undisturbed by the operation. Also, the vital capacity and FEV 1 were only minimally reduced as a result of the operation. The amount of functional lung tissue spared by the operation compared to pneumonectomy was estimated to 39 %. Because of these functional results and the promising 5-year survival figures, we suggest that sleeve lobectomy should be the operation of choice for tumors localized to the upper lobe orifice involving the main bronchus.

This publication has 16 references indexed in Scilit: